2022-11-302023-11-292023-11-29false13736366222 HEALTHCARE SERVICES LIMITED2024-08-27iso4217:GBPxbrli:pure137363662022-11-30137363662023-11-29137363662022-11-302023-11-29137363662021-11-10137363662022-11-29137363662021-11-102022-11-2913736366bus:SmallEntities2022-11-302023-11-2913736366bus:AuditExempt-NoAccountantsReport2022-11-302023-11-2913736366bus:FullAccounts2022-11-302023-11-2913736366bus:PrivateLimitedCompanyLtd2022-11-302023-11-2913736366core:WithinOneYear2023-11-2913736366core:AfterOneYear2023-11-2913736366core:WithinOneYear2022-11-2913736366core:AfterOneYear2022-11-2913736366core:ShareCapital2023-11-2913736366core:SharePremium2023-11-2913736366core:RevaluationReserve2023-11-2913736366core:OtherReservesSubtotal2023-11-2913736366core:RetainedEarningsAccumulatedLosses2023-11-2913736366core:ShareCapital2022-11-2913736366core:SharePremium2022-11-2913736366core:RevaluationReserve2022-11-2913736366core:OtherReservesSubtotal2022-11-2913736366core:RetainedEarningsAccumulatedLosses2022-11-2913736366core:LandBuildings2023-11-2913736366core:PlantMachinery2023-11-2913736366core:Vehicles2023-11-2913736366core:FurnitureFittings2023-11-2913736366core:OfficeEquipment2023-11-2913736366core:NetGoodwill2023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2023-11-2913736366core:ListedExchangeTraded2023-11-2913736366core:UnlistedNon-exchangeTraded2023-11-2913736366core:LandBuildings2022-11-2913736366core:PlantMachinery2022-11-2913736366core:Vehicles2022-11-2913736366core:FurnitureFittings2022-11-2913736366core:OfficeEquipment2022-11-2913736366core:NetGoodwill2022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-2913736366core:ListedExchangeTraded2022-11-2913736366core:UnlistedNon-exchangeTraded2022-11-2913736366core:LandBuildings2022-11-302023-11-2913736366core:PlantMachinery2022-11-302023-11-2913736366core:Vehicles2022-11-302023-11-2913736366core:FurnitureFittings2022-11-302023-11-2913736366core:OfficeEquipment2022-11-302023-11-2913736366core:NetGoodwill2022-11-302023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-302023-11-2913736366core:ListedExchangeTraded2022-11-302023-11-2913736366core:UnlistedNon-exchangeTraded2022-11-302023-11-2913736366core:MoreThanFiveYears2022-11-302023-11-2913736366core:Non-currentFinancialInstruments2023-11-2913736366core:Non-currentFinancialInstruments2022-11-2913736366dpl:CostSales2022-11-302023-11-2913736366dpl:DistributionCosts2022-11-302023-11-2913736366core:LandBuildings2022-11-302023-11-2913736366core:PlantMachinery2022-11-302023-11-2913736366core:Vehicles2022-11-302023-11-2913736366core:FurnitureFittings2022-11-302023-11-2913736366core:OfficeEquipment2022-11-302023-11-2913736366dpl:AdministrativeExpenses2022-11-302023-11-2913736366core:NetGoodwill2022-11-302023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-302023-11-2913736366dpl:GroupUndertakings2022-11-302023-11-2913736366dpl:ParticipatingInterests2022-11-302023-11-2913736366dpl:GroupUndertakingscore:ListedExchangeTraded2022-11-302023-11-2913736366core:ListedExchangeTraded2022-11-302023-11-2913736366dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-11-302023-11-2913736366core:UnlistedNon-exchangeTraded2022-11-302023-11-2913736366dpl:CostSales2021-11-102022-11-2913736366dpl:DistributionCosts2021-11-102022-11-2913736366core:LandBuildings2021-11-102022-11-2913736366core:PlantMachinery2021-11-102022-11-2913736366core:Vehicles2021-11-102022-11-2913736366core:FurnitureFittings2021-11-102022-11-2913736366core:OfficeEquipment2021-11-102022-11-2913736366dpl:AdministrativeExpenses2021-11-102022-11-2913736366core:NetGoodwill2021-11-102022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2021-11-102022-11-2913736366dpl:GroupUndertakings2021-11-102022-11-2913736366dpl:ParticipatingInterests2021-11-102022-11-2913736366dpl:GroupUndertakingscore:ListedExchangeTraded2021-11-102022-11-2913736366core:ListedExchangeTraded2021-11-102022-11-2913736366dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-11-102022-11-2913736366core:UnlistedNon-exchangeTraded2021-11-102022-11-2913736366core:NetGoodwill2023-11-2913736366core:IntangibleAssetsOtherThanGoodwill2023-11-2913736366core:LandBuildings2023-11-2913736366core:PlantMachinery2023-11-2913736366core:Vehicles2023-11-2913736366core:FurnitureFittings2023-11-2913736366core:OfficeEquipment2023-11-2913736366core:AfterOneYear2023-11-2913736366core:WithinOneYear2023-11-2913736366core:ListedExchangeTraded2023-11-2913736366core:UnlistedNon-exchangeTraded2023-11-2913736366core:ShareCapital2023-11-2913736366core:SharePremium2023-11-2913736366core:RevaluationReserve2023-11-2913736366core:OtherReservesSubtotal2023-11-2913736366core:RetainedEarningsAccumulatedLosses2023-11-2913736366core:NetGoodwill2022-11-2913736366core:IntangibleAssetsOtherThanGoodwill2022-11-2913736366core:LandBuildings2022-11-2913736366core:PlantMachinery2022-11-2913736366core:Vehicles2022-11-2913736366core:FurnitureFittings2022-11-2913736366core:OfficeEquipment2022-11-2913736366core:AfterOneYear2022-11-2913736366core:WithinOneYear2022-11-2913736366core:ListedExchangeTraded2022-11-2913736366core:UnlistedNon-exchangeTraded2022-11-2913736366core:ShareCapital2022-11-2913736366core:SharePremium2022-11-2913736366core:RevaluationReserve2022-11-2913736366core:OtherReservesSubtotal2022-11-2913736366core:RetainedEarningsAccumulatedLosses2022-11-2913736366core:NetGoodwill2021-11-1013736366core:IntangibleAssetsOtherThanGoodwill2021-11-1013736366core:LandBuildings2021-11-1013736366core:PlantMachinery2021-11-1013736366core:Vehicles2021-11-1013736366core:FurnitureFittings2021-11-1013736366core:OfficeEquipment2021-11-1013736366core:AfterOneYear2021-11-1013736366core:WithinOneYear2021-11-1013736366core:ListedExchangeTraded2021-11-1013736366core:UnlistedNon-exchangeTraded2021-11-1013736366core:ShareCapital2021-11-1013736366core:SharePremium2021-11-1013736366core:RevaluationReserve2021-11-1013736366core:OtherReservesSubtotal2021-11-1013736366core:RetainedEarningsAccumulatedLosses2021-11-1013736366core:AfterOneYear2022-11-302023-11-2913736366core:WithinOneYear2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-302023-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2023-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-11-2913736366core:Non-currentFinancialInstrumentscore:CostValuation2022-11-2913736366core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-11-2913736366core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-11-2913736366bus:Director12022-11-302023-11-29

222 HEALTHCARE SERVICES LIMITED

Registered Number
13736366
(England and Wales)

Unaudited Financial Statements for the Year ended
29 November 2023

222 HEALTHCARE SERVICES LIMITED
Company Information
for the year from 30 November 2022 to 29 November 2023

Director

LARGE, Oliver Drury Helliwell, Dr

Registered Address

2nd Floor Grove House
55 Lowlands Road
Harrow
HA1 3AW

Registered Number

13736366 (England and Wales)
222 HEALTHCARE SERVICES LIMITED
Balance Sheet as at
29 November 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Intangible assets3137154
Tangible assets44,7312,343
4,8682,497
Current assets
Stocks5450450
Debtors65,3452,330
Cash at bank and on hand8,8553,691
14,6506,471
Creditors amounts falling due within one year7(28,487)(15,490)
Net current assets (liabilities)(13,837)(9,019)
Total assets less current liabilities(8,969)(6,522)
Provisions for liabilities8(1,183)(445)
Net assets(10,152)(6,967)
Capital and reserves
Called up share capital100100
Profit and loss account(10,252)(7,067)
Shareholders' funds(10,152)(6,967)
The financial statements were approved and authorised for issue by the Director on 27 August 2024, and are signed on its behalf by:
LARGE, Oliver Drury Helliwell, Dr
Director
Registered Company No. 13736366
222 HEALTHCARE SERVICES LIMITED
Notes to the Financial Statements
for the year ended 29 November 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Plant and machinery25
Office Equipment25
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
2.Average number of employees

20232022
Average number of employees during the year22
3.Intangible assets

Other

Total

££
Cost or valuation
At 30 November 22170170
At 29 November 23170170
Amortisation and impairment
At 30 November 221616
Charge for year1717
At 29 November 233333
Net book value
At 29 November 23137137
At 29 November 22154154
4.Tangible fixed assets

Plant & machinery

Office Equipment

Total

£££
Cost or valuation
At 30 November 22852,6452,730
Additions3,190-3,190
At 29 November 233,2752,6455,920
Depreciation and impairment
At 30 November 228379387
Charge for year236566802
At 29 November 232449451,189
Net book value
At 29 November 233,0311,7004,731
At 29 November 22772,2662,343
5.Stocks

2023

2022

££
Raw materials and consumables450450
Total450450
6.Debtors: amounts due within one year

2023

2022

££
Trade debtors / trade receivables1,640214
Other debtors486309
Prepayments and accrued income3,2191,807
Total5,3452,330
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
7.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables5,5461,110
Other creditors18,86110,663
Accrued liabilities and deferred income4,0803,717
Total28,48715,490
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
8.Provisions for liabilities

2023

2022

££
Net deferred tax liability (asset)1,183445
Total1,183445
9.Guarantees provided on behalf of directors
The director's current account balance of £537 (2022:£463) relates to the director.